<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJPed</journal-id><journal-title-group><journal-title>Open Journal of Pediatrics</journal-title></journal-title-group><issn pub-type="epub">2160-8741</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojped.2018.84036</article-id><article-id pub-id-type="publisher-id">OJPed-89443</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Post-Infectious Acute Glomerulonephritis in Child: Epidemiological, Clinical and Evolutionary Aspects in Gabriel Tour&#233; Teaching Hospital in Mali
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mariam</surname><given-names>Sylla</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fatoumata</surname><given-names>Dicko-Traoré</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoul</surname><given-names>Karim Doumbia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aminata</surname><given-names>Coulibaly</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoul</surname><given-names>Aziz Diakité</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Modibo</surname><given-names>Sangaré</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pierre</surname><given-names>Togo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fousseyni</surname><given-names>Traoré</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Amadou</surname><given-names>Touré</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Djènèba</surname><given-names>Konaté</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Karamoko</surname><given-names>Sacko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Belco</surname><given-names>Maiga</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fatoumata</surname><given-names>Léonie Diakité</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lala</surname><given-names>N’Drainy Sidibé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohamed</surname><given-names>Elmouloud Cissé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adama</surname><given-names>Dembélé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hawa</surname><given-names>Diall</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Oumar</surname><given-names>Coulibaly</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ibrahim</surname><given-names>Hamadou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Leyla</surname><given-names>Maiga</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Issiaka</surname><given-names>Koné</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Boubacar</surname><given-names>Togo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Toumani</surname><given-names>Sidibé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Pediatrics, CHU Gabriel Touré, Bamako, Mali</addr-line></aff><aff id="aff2"><addr-line>Faculty of Medecine and Odontostomatology, Bamako, Mali</addr-line></aff><pub-date pub-type="epub"><day>14</day><month>11</month><year>2018</year></pub-date><volume>08</volume><issue>04</issue><fpage>366</fpage><lpage>374</lpage><history><date date-type="received"><day>25,</day>	<month>November</month>	<year>2018</year></date><date date-type="rev-recd"><day>23,</day>	<month>December</month>	<year>2018</year>	</date><date date-type="accepted"><day>26,</day>	<month>December</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: 
  Acute post-infectious glomerulonephritis (APIGN) can be serious due to its complications that still occur in our countries. In this work, we aimed to study the epidemiological, clinical, biological and evolutionary aspects of APIGN. <b>Patients and methods:</b> We conducted a retrospective, descriptive study from January 1<sup>st</sup>, 2015 to December 31<sup>st</sup>, 2017 in the pediatric ward 
  of the Gabriel Tour&#233; Teaching Hospital in Bamako
  . All children hospitalized for APIGN were included. <b>Results:</b> In two years, we included 10 children aged 7 years old on average
  ;
   all from low socioeconomic backgrounds. The sex ratio was 1.5. On average, the children spent 15.8 days before our consultation. Edema was the main reason for consultation. We found a history of infection and high blood pressure in 30% each, and renal failure in 10% of the children. Hematuria and proteinuria were detected in 100% and 90%, respectively. Hypocomplementemia was observed in 66.6%. One third of the children had a positive antistreptolysin O. The average duration of hospital stay was 11.2 days. The evolution was favorable in 90%. Kidney failure was the leading cause of death. <b>Conclusion:</b>
  <b> </b>
  Acute post-infectious glomerulonephritis is still a reality in our context. Emphasis should be put on its prevention by improving the hygienic conditions, detection and the management of infections.
 
</p></abstract><kwd-group><kwd>Glomerulonephritis</kwd><kwd> Infection</kwd><kwd> Pediatrics</kwd><kwd> Mali</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Acute post-infectious glomerulonephritis (APIGN) is defined by a non suppurative acute inflammatory aggression with glomerular predominance [<xref ref-type="bibr" rid="scirp.89443-ref1">1</xref>]. APIGN is the second infantile nephropathy after nephrotic syndrome [<xref ref-type="bibr" rid="scirp.89443-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref4">4</xref>]. APIGN is mostly caused by group A β-hemolytic streptococcus, but any infectious agent (bacteria, virus, fungal, parasite) can be causative [<xref ref-type="bibr" rid="scirp.89443-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref5">5</xref>].</p><p>The incidence of APIGN is not well known due to the frequency of infra-clinical forms [<xref ref-type="bibr" rid="scirp.89443-ref1">1</xref>]. APIGN is in significant decrease in countries where health coverage and hygiene conditions are sufficient [<xref ref-type="bibr" rid="scirp.89443-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref8">8</xref>]. Proper management of streptococcal infections resulted in extreme rarity of the condition in France [<xref ref-type="bibr" rid="scirp.89443-ref9">9</xref>]. APIGN still exists in Africa and remains an important cause of renal lesions in children [<xref ref-type="bibr" rid="scirp.89443-ref2">2</xref>]. APIGN can be severe and may lead to a fatal renal insufficiency in children [<xref ref-type="bibr" rid="scirp.89443-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref6">6</xref>]. In Mali, urinary tract pathology represents 1% of all hospital stays in the pediatrician department of the University hospital Gabriel Toure, the national reference structure [<xref ref-type="bibr" rid="scirp.89443-ref3">3</xref>]. APIGN is the third most frequent pathology (12.5%) behind nephrotic syndrome (43.1%) and urinary infection (22.2%) [<xref ref-type="bibr" rid="scirp.89443-ref3">3</xref>]. Despite its frequency, no study was yet carried out to describe the profile of children with APIGN. This work aimed to determine the epidemiologic, clinical, biological and evolutive characteristics of APIGN in the Malian context.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>We conducted a 2-year retrospective study from January 1<sup>st</sup>, 2015 to December 31<sup>st</sup>, 2017 in the pediatrician department of the Gabriel Tour&#233; teaching hospital in Bamako, the capital city of Mali. Our department is the highest reference structure in the country. Its ensure the care of either children referred from all over the country at every level of the national health pyramid or those accompanied by their parents from downtown and suburban areas of Bamako.</p><p>We reviewed the medical charts of children aged 1 month to 15 years old, hospitalized for APIGN. The variables studied were: socio-demographic characteristics (sex, age, socioeconomic level), clinical (weight, signs, complications), evolutionary (immediate becoming).</p><p>The clinical operational definition we adopted for APIGN was the presence of edema associated with at least another element of nephritic syndrome (hematuria, proteinuria, high blood pressure, or oliguria).</p><p>Socio-economic conditions were appreciated with the Chauliac M and Ag Bendech method [<xref ref-type="bibr" rid="scirp.89443-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref11">11</xref>]. This method is based on the residency, type of housing, profession of the child’s father, and the family earnings. This allows us to classify the socio-economic ranking: high, intermediate and low.</p><p>Oliguria was considered when the diuresis was to 2 mL/kg/hour [<xref ref-type="bibr" rid="scirp.89443-ref12">12</xref>].</p><p>High blood pressure was defined when the diastolic and systolic blood pressures were ≥95 percentile [<xref ref-type="bibr" rid="scirp.89443-ref13">13</xref>].</p><p>Proteinuria was defined by a rate superior to 150 mg/day and was nephrotic when superior to 50 mg/kg/day.</p><p>Complement C3 fraction was labeled low when inferior to 0.82 g/L, elevated creatininemia when superior a 110 &#181;mol/L, elevated uremia when superior to 7.6 mmol/L and anti-streptolysin (ASLO) was positive when superior to 200 UI/mL [<xref ref-type="bibr" rid="scirp.89443-ref12">12</xref>].</p><p>Creatinine clearance was not determined and no renal biopsy was performed.</p><p>Anemia was defined according the WHO [<xref ref-type="bibr" rid="scirp.89443-ref14">14</xref>] : Hemoglobin inferior to 11 g/dL before 5 years old, inferior to 11.5 g/dL between 5 and 11 years old, inferior to 12 g/dL after 11 years old. Anemia was considered severe at the Hb &lt; 7 g/dL and &lt;8 g/dl before and after 5 years old, respectively.</p></sec><sec id="s3"><title>3. Results</title><p>During the 2-year study period, 6087 patients were hospitalized in the above mentioned department. The hospital frequency of APIGN was 0.16% (10/6087).</p><p>The sex ratio was 1.5 (six boys for three girls). The mean age was 7 years old with the extremes of 1 - 13 years old. Children less than 5 years old and those more than 10 years old represented 30% and 40%, respectively. All patients were from a low socio-economic ranking. The disease onset was more likely to happen in winter (60%).</p><p>Oedema was limited to the face (20%) or generalized (80%) and was the most frequent reason for outpatient visits. About one third of the patients (30%) had a history of infection such as suppurative otitis, pyodermitis, and abscess of the upper limb preceding the onset of the APIGN. The delay period between the onset and the outpatient visit varied from 4 to 37 days with a mean of 15.8 days.</p><p>All the patients had modified urine color and 90% of them had hematuria evidenced by urine sticks. Three patients (30%) had high blood pressure at the admission. Convulsive crisis revealed the disease in one patient. One patient had oliguria; 30% had fever; and 20% had pneumonia.</p><p>Proteinuria was found in 90% of the patients, and was mostly non nephrotic with 338.88 mg/24hours. Blood protein level was low in three fourth of the patients. Complement C3 was lower in 4 out of six patients (66.66%) who had its dosage. ASLO was positive in two out of three patients. A patient had oliguria with hyper-creatinemia at 731.90 μmol/L. Two patients had creatininemia of 133 &#181;mol/L and 135 &#181;mol/L, respectively. Uremia was concomitantly elevated with creatininemia in three patients. Uremia was normal in all the remaining patients.</p><p>Anemia was present in all the patients, but severe in only 30%. The outcome was favorable in 90% of the patients with a complete regression of the oedema and the normalization of the creatininemia before the discharge from the hospital. The only complication found was kidney failure found in a child. This child passed away due to this renal insufficiency.</p><p>Water restriction and low sodium diet were prescribed in all patients. Antidiuretic treatment (furosemide) was done in 70% of patients. Antihypertensives (calcium channel blockers or converting enzyme inhibitors) have been prescribed in patients with high blood pressure.</p><p>The mean hospital stay was 11.2 days with the extremes of 6 and 42 days.</p><p>The main characteristics of patients are summarized in <xref ref-type="table" rid="table1">Table 1</xref>.</p></sec><sec id="s4"><title>4. Discussion</title><p>Acute post-infectious glomerulonephritis occupies an important place among the infantile nephropathies [<xref ref-type="bibr" rid="scirp.89443-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref16">16</xref>]. APIGN is the most frequent renal pathology in Nepal (37.7%) [<xref ref-type="bibr" rid="scirp.89443-ref15">15</xref>], the third and fourth most frequent urinary tract pathologies in Ethiopia (12.2%) [<xref ref-type="bibr" rid="scirp.89443-ref16">16</xref>] and in Cote d’Ivoire (12.9%) [<xref ref-type="bibr" rid="scirp.89443-ref3">3</xref>].</p><p>The hospital frequency of APIGN is diversely appreciated in the literature. It varies from 0.16% with five per year on average to 2.65% in the pediatrician department of the Teaching Hospital of Donka, Guinea [<xref ref-type="bibr" rid="scirp.89443-ref17">17</xref>]. In Iran, Sepahi MA et al., collected 94 cases in six years with an annuel incidence of 15.66 [<xref ref-type="bibr" rid="scirp.89443-ref18">18</xref>] versus 6.66 per year in Delta State Teaching Hospitalin Nigeria in 2015 [<xref ref-type="bibr" rid="scirp.89443-ref19">19</xref>] and 7.7 cases per year in Congo [<xref ref-type="bibr" rid="scirp.89443-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref16">16</xref>].</p><p>The divergence between these results can be explained by the definition criteria of APIGN, the study type, and the inclusion crieteria. The prevalence of APIGN is in decrease in most of the industrialized countries [<xref ref-type="bibr" rid="scirp.89443-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref20">20</xref>].</p><p>Although this study is retrospective, essential limit of this work, it allowed to appreciate the characteristics of post-infectious acute glomerulonephritis in our context.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Summary of the main characteristics of patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Patient</th><th align="center" valign="middle" >Age (year old)/Sex*</th><th align="center" valign="middle" >causal Infection</th><th align="center" valign="middle" >H&#233;maturia**</th><th align="center" valign="middle" >C3 (g/L)</th><th align="center" valign="middle" >Creatininemia (&#181;mol/L)</th><th align="center" valign="middle" >Prot&#233;inuria/24 H (mg/day)</th><th align="center" valign="middle" >Evolution</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >9/F</td><td align="center" valign="middle" >Suppurative otitis</td><td align="center" valign="middle" >++++</td><td align="center" valign="middle" >1.16</td><td align="center" valign="middle" >731.90</td><td align="center" valign="middle" >799.00</td><td align="center" valign="middle" >Passedaway</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >12/F</td><td align="center" valign="middle" >Limb abces</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >135.00</td><td align="center" valign="middle" >26.24</td><td align="center" valign="middle" >Favorable</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >6/M</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >++</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >46.27</td><td align="center" valign="middle" >292.00</td><td align="center" valign="middle" >Favorable</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2/M</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >++</td><td align="center" valign="middle" >0.34</td><td align="center" valign="middle" >53.35</td><td align="center" valign="middle" >90.00</td><td align="center" valign="middle" >Favorable</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >8/M</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >0.42</td><td align="center" valign="middle" >85.70</td><td align="center" valign="middle" >149.85</td><td align="center" valign="middle" >Favorable</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >12/F</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >++</td><td align="center" valign="middle" >1.48</td><td align="center" valign="middle" >33.09</td><td align="center" valign="middle" >829.87</td><td align="center" valign="middle" >Favorable</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >5/F</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >+++</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >60.13</td><td align="center" valign="middle" >379.72</td><td align="center" valign="middle" >Favorable</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >13/F</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >133.00</td><td align="center" valign="middle" >238.14</td><td align="center" valign="middle" >Favorable</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >1/M</td><td align="center" valign="middle" >Pyodermitis</td><td align="center" valign="middle" >++</td><td align="center" valign="middle" >0.52</td><td align="center" valign="middle" >62.52</td><td align="center" valign="middle" >54.00</td><td align="center" valign="middle" >Favorable</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >13/M</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >0.10</td><td align="center" valign="middle" >29.54</td><td align="center" valign="middle" >61.13</td><td align="center" valign="middle" >Favorable</td></tr></tbody></table></table-wrap><p>*Sex: M = Male, F = Female; **Hematuria appreciated with urinary sticks.</p><p>The mean age of the patients was 7 years old similarly to the findings in many studies [<xref ref-type="bibr" rid="scirp.89443-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref19">19</xref>]. Assambo-Kieli C [<xref ref-type="bibr" rid="scirp.89443-ref2">2</xref>] found a mean age of 12.6 years old. Most of our patients were aged &gt;10 years old as compared to 30% over 14 years old in Maroc [<xref ref-type="bibr" rid="scirp.89443-ref21">21</xref>] allowing the author Razzouki K to suggest that APIGN was becoming a pathology of teenagers. Male predominance was found in our cohort and in many other studies [<xref ref-type="bibr" rid="scirp.89443-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref17">17</xref>].</p><p>The frequency of APIGN is strongly influenced by the socio-economic status. All our patients were deprived from low socio-economic ranking. McGilUgwu also found (60%) of such patients in Nigeria [<xref ref-type="bibr" rid="scirp.89443-ref19">19</xref>]. Mola K suggested that insufficient sensibilization of families and the ignorance of early alarming signs are the favoring factors of APIGN in poor neighborhood.</p><p>The lack of information on APIGN can explained the long delay of 15 days between the onset of the disease and the first outpatient visit in Mali and at the University hospital of Addis-Abeba in Ethiopia [<xref ref-type="bibr" rid="scirp.89443-ref16">16</xref>]. The commonest form of APIGN occurs in communities with low socio-economic status and poor hygiene conditions living in promiscuity [<xref ref-type="bibr" rid="scirp.89443-ref5">5</xref>]. Certain environmental factors may influence the occurrence of the causal infection of APIGN. Winter was incriminated in our study and in Guinea by Bah O [<xref ref-type="bibr" rid="scirp.89443-ref17">17</xref>] who suggested that frequent respiratory tract infections in winter is a possible explanation the association between APIGN and winter. Bayahia R found that APIGN is seasonal resulting from rhino-pharyngeal infections in winter and skin infections in spring [<xref ref-type="bibr" rid="scirp.89443-ref5">5</xref>].</p><p>We found no causal infection in 30% of the patients. In fact, in our context, causal infections are often silent or ignored. In Guinea, sore throat (60.4%) and suppurative otitis (16.2%) were the most frequent causal infections [<xref ref-type="bibr" rid="scirp.89443-ref17">17</xref>]. In India, Gunasekaran K mainly found pyo-dermitis in 80.6% and few cases of varicella and measles [<xref ref-type="bibr" rid="scirp.89443-ref22">22</xref>]. In Nigeria, McGilUgwu GI [<xref ref-type="bibr" rid="scirp.89443-ref19">19</xref>] suspected streptococcal infection in 35%. VanDeVoorde RG [<xref ref-type="bibr" rid="scirp.89443-ref20">20</xref>], assumed that proper management of infections has decreased this form of APIGN worldwide in general. Two of our patients had pneumonia in which we could neither find the germ nor associate it with APIGN. In 2013, Vitaliti G [<xref ref-type="bibr" rid="scirp.89443-ref23">23</xref>] in Italy, reported a 3-year old infant with APIGN secondary to a Chlamydia pneumoniae pulmonary infection.</p><p>Clinically, we recruited typical presentations of APIGN as described in the literature with few exceptions due to the variability of the inclusion criteria. Oedema, often generalized, was the main reason for outpatient visit in Guinea [<xref ref-type="bibr" rid="scirp.89443-ref17">17</xref>], Nigeria [<xref ref-type="bibr" rid="scirp.89443-ref19">19</xref>] and Iran [<xref ref-type="bibr" rid="scirp.89443-ref18">18</xref>] similar to our study. This reinforces the feeling that only visible and worrisome signs motivate medical management in low socio-economic setting. The presence of hematuria with urines “porto”, “bouillon sale”, “coca” can be the revealing sign of the disease [<xref ref-type="bibr" rid="scirp.89443-ref24">24</xref>]. We found hematuria in 69% of the patients versus 100% in a study in Niger [<xref ref-type="bibr" rid="scirp.89443-ref19">19</xref>]. High blood pressure was found in one third of the patients, 39% in the cohort of Bah O [<xref ref-type="bibr" rid="scirp.89443-ref17">17</xref>], over half of the patients in Nigeria [<xref ref-type="bibr" rid="scirp.89443-ref19">19</xref>] and in 82.4% patients in Israel [<xref ref-type="bibr" rid="scirp.89443-ref7">7</xref>]. Surprisingly, Sepahi MA found no cases of hematuria in Iran [<xref ref-type="bibr" rid="scirp.89443-ref18">18</xref>].</p><p>Proteinuria was present in 90% of our patients, but none reached a level of nephrotic proteinuria, an actually frequent finding in APIGN [<xref ref-type="bibr" rid="scirp.89443-ref7">7</xref>]. Nephrotic proteinuria in APIGN patients was reported in 54.48% in Congo, 18% in Marocet 22.9% in Isreal. In nephrotic syndrome, which is often transient in APIGN, electrophoresis of proteins can reveal a normal or low level plasmatic protein level with hypoalbuminemia [<xref ref-type="bibr" rid="scirp.89443-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref17">17</xref>]. Three fourth of our patients had hypoproteinemia. Thomas R [<xref ref-type="bibr" rid="scirp.89443-ref24">24</xref>] said, “a low grade hypoalbuminemia is typical in many inflammatory processes, but values inferior to 2 g/dL are unusual and suggest an association of nephrotic syndrome”.</p><p>Complement C3 fraction was low in two third of the patients. According to Dagan R, hypo-complementemia was correlated to age and more frequent in older infants and teenagers [<xref ref-type="bibr" rid="scirp.89443-ref7">7</xref>]. Some authors viewed hypo-complementemia as a poor prognostic factor [<xref ref-type="bibr" rid="scirp.89443-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref25">25</xref>], but others support that it is a major sign of post-streptococcal APIGN [<xref ref-type="bibr" rid="scirp.89443-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref26">26</xref>]. Consequently, ASLO is elevated in the first 15 days and decreases up to becoming normal after few months [<xref ref-type="bibr" rid="scirp.89443-ref5">5</xref>]. To optimize the diagnostic of streptococcal infection, at least two subsequent measurements of ASLO along a simultaneous dosage of anti-DNASE B are necessary [<xref ref-type="bibr" rid="scirp.89443-ref26">26</xref>]. Only 30% of our patients benefited from two dosages of ASLO with positive results for a single patient as compared to 37% positive ASLO at the University hospital in Donka, Guinea [<xref ref-type="bibr" rid="scirp.89443-ref17">17</xref>].</p><p>Acute renal insufficiency can reveal or complicate APIGN [<xref ref-type="bibr" rid="scirp.89443-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref24">24</xref>]. The mean creatininemia was 173.4 &#181;mol/l with the extremes of 33.09 &#181;mol/l and 731.90 &#181;mol/l in our cohort. Renal insufficiency was diagnosed in Congo (16%), Guinea (34.5%) and India (20.8%) [<xref ref-type="bibr" rid="scirp.89443-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref22">22</xref>] of APIGN patients and was identified as a poor prognostic factor [<xref ref-type="bibr" rid="scirp.89443-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref28">28</xref>].</p><p>Anemia was present in 100% in our cohort and 90% in Nigeria [<xref ref-type="bibr" rid="scirp.89443-ref19">19</xref>]. Anemia was severe in one third of our patients comparable to 35% in Guinea [<xref ref-type="bibr" rid="scirp.89443-ref17">17</xref>]. Anemia by hemodilution is frequent in glomerulonephritis (GN) [<xref ref-type="bibr" rid="scirp.89443-ref24">24</xref>]. Nevertheless, in the presence of severe anemia, the search for another chronic cause is justified [<xref ref-type="bibr" rid="scirp.89443-ref24">24</xref>]. Diouf et al., reported 72% of anemia from his study in 11 French speaking African countries in 2015 [<xref ref-type="bibr" rid="scirp.89443-ref29">29</xref>]. Malaria is another important cause of anemia in our context [<xref ref-type="bibr" rid="scirp.89443-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref29">29</xref>]. When the causal germ is Plasmodium malariae, anemia results in “quartane” nephropathie and membrano-proliferative GN [<xref ref-type="bibr" rid="scirp.89443-ref30">30</xref>].</p><p>The evolution of APIGN was favorable in 90% in our cohort and 95% in Nigeria [<xref ref-type="bibr" rid="scirp.89443-ref19">19</xref>]. Many authors consider properly managed APIGN a benign condition [<xref ref-type="bibr" rid="scirp.89443-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref24">24</xref>] regardless of the possibility of complications such as renal insufficiency [<xref ref-type="bibr" rid="scirp.89443-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.89443-ref28">28</xref>].</p></sec><sec id="s5"><title>5. Conclusion</title><p>Very rare in developed countries, APIGN still remains a reality in our context. Long delays before the medical visit are due to the scarcity of living conditions of the families. Diagnostic and management are consequently delayed. Complications are dreadful and prevention is essential. Hygiene conditions should be improved and infections should be rigorously managed in children.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Sylla, M., Dicko-Traor&#233;, F., Doumbia, A.K., Coulibaly, A., Diakit&#233;, A.A., Sangar&#233;, M., Togo, P., Traor&#233;, F., Tour&#233;, A., Konat&#233;, D., Sacko, K., Maiga, B., Diakit&#233;, F.L., Sidib&#233;, L.N., Ciss&#233;, M.E., Demb&#233;l&#233;, A., Diall, H., Coulibaly, O., Hamadou, I., Maiga, L., Kon&#233;, I., Togo, B. and Sidib&#233;, T. (2018) Post-Infectious Acute Glomerulonephritis in Child: Epidemiological, Clinical and Evolutionary Aspects in Gabriel Tour&#233; Teaching Hospital in Mali. Open Journal of Pediatrics, 8, 366-374. https://doi.org/10.4236/ojped.2018.84036</p></sec></body><back><ref-list><title>References</title><ref id="scirp.89443-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Ramdani, B., Zamd, M., Hachim, K., Soulami, K., Ezzahidy, M., Souiri, M., et al. (2012) Acute Post-Infectious Gomerulonephritis. Néphrologie &amp; Thérapeutique, 8, 247-258. https://doi.org/10.1016/j.nephro.2011.11.011</mixed-citation></ref><ref id="scirp.89443-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Assambou-Kieli, C., Moyen, G., Etokabeka, F. and Nzingoula, S. (1995)Acute Post-Infectious Gomerulonephritis: Epidemiological, Clinical and Evolutionary Aspect: About 31 Cases at the Teaching Hospital of Brazzaville. Médecine d’Afrique noire, 42, 300-303.</mixed-citation></ref><ref id="scirp.89443-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Coulibaly, P.N.A., Cissé, L., Diarrassouba, G., Egesi, M., Tia, W.M., Ouattara, G.J. and Oulai, S. (2015) Renal and Urinary Diseases of Hospitalized Children in the Pediatric Ward of the Teaching Hospital of Treichville (Abidjan). Médecine d’Afrique noire, 62, 321-326.</mixed-citation></ref><ref id="scirp.89443-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ministry of Health and Public Hygiene of the Republic of Mali and National Directorate of Health and Gabriel Touré Teaching Hospital (2017) Activity Report of the Department of Pediatrics. 37 p.</mixed-citation></ref><ref id="scirp.89443-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Ministry of Health of the Kingdom of Morocco (2012) Good Medical Practice Recommendations: Glomerulonephritis. 43 p.  
http://nephro-maroc.com/wp-content/uploads/2016/03/guide_glomerulonephrit</mixed-citation></ref><ref id="scirp.89443-ref6"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Francois-Pradier</surname><given-names> H. </given-names></name>,<etal>et al</etal>. (<year>2016</year>)<article-title>Post Infectious or Infectious Glomerulonephritis</article-title><source> La Revue du praticien</source><volume> 66</volume>,<fpage> 1115</fpage>-<lpage>1120</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.89443-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Dagan, R., Cleper, R., Davidovits, M., Sinai-Trieman, L. and Krause, I. (2016) Post-Infectious Gomerulonephritis in Pediatric Patients over Two Decades: Severity-Associated Features. The Israel Medical Association Journal, 18, 336-340.</mixed-citation></ref><ref id="scirp.89443-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Kambham, N. (2012) Post Infectious Glomerulonephritis. Advances in Anatomic Pathology, 19, 338-347. https://doi.org/10.1097/PAP.0b013e31826663d9</mixed-citation></ref><ref id="scirp.89443-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Le-Berre, N., Filipozzi, P., Martin, L., Frimat, L. and Girerd, S. (2017) First Case Report of Streptococcus equi Subsp. Zooepidemicus Post-Infectious Acute Glomerulonephritis in France. Néphrologie &amp; Thérapeutique, 13, 37-41.  
https://doi.org/10.1016/j.nephro.2016.07.448</mixed-citation></ref><ref id="scirp.89443-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Chauliac, M., Bricas, N., Ategbo, E.A., Amoussa, W. and Zohoun, I. (1998) Alimentaion out of the Home of Schoolchildren in Cotonou (Benin). Santé, 8, 101-108.</mixed-citation></ref><ref id="scirp.89443-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Ag Bendech, M., Chauliac, M. and Malvy, D. (1996) Variability of Home-Based Dietary Practices of Families Living in Bamako (Mali) According to Socio-Economic Levels. Cahiers Santé, 6, 285-97.</mixed-citation></ref><ref id="scirp.89443-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Hogg, R.J., Portman, R.J. and Milliner, D. (2000) Evaluation and Management of Proteinuria and Nephrotic Syndrome in Children: Recommandations from a Pediatric Nephrology Panel Established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE). Pediatrics, 105, 1242-1249. https://doi.org/10.1542/peds.105.6.1242</mixed-citation></ref><ref id="scirp.89443-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescent (2004) The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescent. Pediatrics, 114, 555-576. https://doi.org/10.1542/peds.114.2.S2.555</mixed-citation></ref><ref id="scirp.89443-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organisation (2011) Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. 6 p.  
http://www.who.int/vmnis/indicators/haemoglobin.pdf</mixed-citation></ref><ref id="scirp.89443-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Yadav, S.P., Shah, G.S., Mishra, O.P. and Baral, N. (2016) Pattern of Renal Diseases in Children: A Developing Country Experience. Saudi Journal of Kidney Disease and Transplantation, 27, 371-376. https://doi.org/10.4103/1319-2442.178565</mixed-citation></ref><ref id="scirp.89443-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Mola, K. and Shimelis, D. (2016) Pattern and Outcome of Renal Diseases in Hospitalized Children in TikurAnbessa Specialized Teaching Hospital, Addis Ababa, Ethiopia. Ethiopian Medical Journal, 54, 117-123.</mixed-citation></ref><ref id="scirp.89443-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Bah, A.O., Diallo, S.B. and Kaba, M.L. (2006) Post-Infectious Acute Glomerulonephritis of the Child: Epidemiological and Clinical Aspects in the Pediatric Ward of the Donka Teaching Hospital, Conakry. Rev. Int. Sc. Méd., 8, 31-34.</mixed-citation></ref><ref id="scirp.89443-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Sepahi, M.A., Shajari, A., Shakiba, M., Shooshtary, F.K. and Salimi, M.H. (2011) Acute Glomerulonephritis: A 7 Years Follow Up of Children in Center of Iran. Acta MedicaIranica, 49, 375-378.</mixed-citation></ref><ref id="scirp.89443-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">McGilUgwu, G.I. (2015) Acute Glomerulonephritis in Children of the Niger Delta Region of Nigeria. Saudi Journal of Kidney Disease and Transplantation, 26, 1064-1069. https://doi.org/10.4103/1319-2442.164618</mixed-citation></ref><ref id="scirp.89443-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">VanDeVoorde, R.G. (2015) Acute Poststreptococcal Glomerulonephritis: The Most Common Acute Glomerulonephritis. Pediatrics in Review, 36, 3-12.  
https://doi.org/10.1542/pir.36-1-3</mixed-citation></ref><ref id="scirp.89443-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Razzouki, K., Elbouaychi, M., Bourrahouate, A., Sbihil, M. and Sab, A. (2014) Acute Post-Infectious Gomerulonephritis: Is It Still a Benigne Disease? Archives de Pédiatrie, 21, 770. https://doi.org/10.1016/S0929-693X(14)72030-5</mixed-citation></ref><ref id="scirp.89443-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Gunasekaran, K., Krishnamurthy, S., Mahadevan, S., Harish, B.N. and Kumar, A.P. (2015) Clinical Characteristics and Outcome of Post-Infectious Glomerulonephritis in Children in Southern India: A Prospective Study. Indian Journal of Pediatrics, 82, 896-903. https://doi.org/10.1007/s12098-015-1752-0</mixed-citation></ref><ref id="scirp.89443-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Vitaliti, G., Falsaperla, R., Giunta, L., Spataro, G., Rapisarda, V., Velardita, M., et al. (2013) Acute Glomerulonephritis in a Child with Chlamydia pneumoniae Infection: A Case Report. Case Reports in Medicine, 2013, Article ID: 570921.</mixed-citation></ref><ref id="scirp.89443-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Thomas, R.W. (2002) An Approche to the Child with Acute Glomerulonephritis. International Journal of Pediatrics, 2002, Article ID: 426192.  
https://doi.org/10.1155/2012/426192</mixed-citation></ref><ref id="scirp.89443-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Becquet, O., Pasche, J., Gatti, H., Claude, C., Abély, M., Morville, P., et al. (2010) Post-Streptococcal Glomerulonephritis in Children in French Polynesia: A 3-Year Retrospective Study. Pediatric Nephrology, 25, 275-280.  
https://doi.org/10.1007/s00467-009-1325-4</mixed-citation></ref><ref id="scirp.89443-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Sen, E.S. and Ramanan, A.V. (2014) How to Use Antistreptolysin O Titre. Archives of Disease in Childhood—Education and Practice, 99, 231-238.  
https://doi.org/10.1136/archdischild-2013-304884</mixed-citation></ref><ref id="scirp.89443-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Jellouli, M., Maghraoui, S., Abidi, K., Hammi, Y., Goucha, R., Naija, O., et al. (2015) Outcome of Rapidly Progressive Glomerulonephritis Post-Streptococcal Disease in Children. Néphrologie &amp; Thérapeutique, 11, 487-491.  
https://doi.org/10.1016/j.nephro.2015.04.005</mixed-citation></ref><ref id="scirp.89443-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Piyaphanee, N., Ananboontarick, C., Supavekin, S. and Sumboonnanonda, A. (2016) Renal Outcome and Risk Factors for End-Stage Renal Disease in Pediatric Rapidly Progressive Glomerulonephritis. Pediatrics International, 59, 334-341.  
https://doi.org/10.1111/ped.13140</mixed-citation></ref><ref id="scirp.89443-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Diouf, S., Folquet, M., Mbofung, K., Ndiaye, O., Brou, K., Dupont, C., et al. (2015) Prevalence and Determinants of Anemia in Young Children in French-Speaking Africa-Involvement of Iron Deficiency. Archives de Pédiatrie, 22, 1188-1197.  
https://doi.org/10.1016/j.arcped.2015.08.015</mixed-citation></ref><ref id="scirp.89443-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Raharivelina, C., Andrianarison, L. and Rakotoarivelo, R. (2009) Un cas de glomérulonéphrite membrano-proliférative d’origine paludéenne: Néphropathie quartane? Médecine d’Afrique Noire, 56, 289-393.</mixed-citation></ref></ref-list></back></article>